
“After progress in a second round of tests using stem cells to regrow nerve fibres, the China Spinal Cord Injury Network (ChinaSCINet) has applied for regulatory approval in China for a third and final phase, which it hopes to start in the autumn. 15 out of 20 patients in the Chinese city of Kunming, who received umbilical cord blood cell transplants and intensive walking therapy, were on average able to walk with minimal assistance seven years after complete spinal cord injury. The treatment involves injecting umbilical cord blood mononuclear cells into patients’ damaged spines to help regenerate nerves, while lithium is used to promote the growth of the nerve fibres.”
Related posts:
Benghazi air space shut over security fears: Libya source
Russians discover four vats of embryos during stroll in the woods
Money fund loses 0.3% of clients’ money to bailed-out African Bank
Termites Feast On Woman's Life Savings
U.S. and Europe block ‘treaty for blind people’ due to copyright concerns
China Overtakes Sluggish Europe in Car Sales
UK tax office to get power to raid bank accounts without court order
Florida mom arrested after letting 7-year-old walk to the park alone
Der Spiegel: Public Must Fight against Prism and Tempora Surveillance
Health Insurance Companies Seek Big Rate Increases for 2016
French-led forces in Mali take Timbuktu airport, enter city
Australian Central Bank Cuts Key Rate to Record-Low 2.75%
Estonia launches national car-charging network
FoxConn will pay Microsoft royalties to produce Android, Chrome phones and televisions
Egypt army opens fire on pro-Morsi protesters